Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get AMRX alerts

About Jeff George

Jeff George is recorded as Board Member at Amneal Pharmaceuticals, Inc. (AMRX), Chairman at LENZ Therapeutics, Inc. (LENZ) since March 21, 2024 and Board Member at LENZ Therapeutics, Inc. (LENZ) since January 1, 2024. The newest filing on record that lists Jeff George as Board Member at Amneal Pharmaceuticals, Inc. (AMRX) is dated March 25, 2026. The newest filing on record that lists Jeff George as Board Member at LENZ Therapeutics, Inc. (LENZ) is dated April 28, 2026. LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Jeff George was appointed Chair of the Board, effective March 21, 2024. LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Jeff George was appointed Class II director, effective March 21, 2024. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. LENZ Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Paul Meister (Chairman and Board Member) and 7 others.

“Also on March 21, 2024, Mr. George was appointed as the Chair of the Board.”
LENZ Therapeutics, Inc. Form 8-K, filed March 22, 2024 · Read the filing
“Effective as of the Effective Time, Frederic Guerard and James McCollum were appointed as Class I directors, Jeff George, Shelley Thunen, and Evert Schimmelpennink were appointed as Class II directors and Kimberlee C. Drapkin and Zach Scheiner were appointed as Class III directors.”
LENZ Therapeutics, Inc. Form 8-K, filed March 22, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Amneal Pharmaceuticals, Inc.

Leadership on record at LENZ Therapeutics, Inc.

Recent activity